FDA approves first drug for serious liver disease
The U.S. Food and Drug Administration (FDA) has approved the first drug to treat serious liver disease, the agency announced in a release Thursday. The FDA approved Rezdiffra (resmetirom) for the treatment of adults with a common form of liver inflammation called nonalcoholic steatohepatitis, or NASH. NASH, also known as metabolic dysfunction-associated steatohepatitis, or MASH,...
